DMITRY PARSHIN, Vyacheslav Mykhaylichenko, A. Kupriyanov, Ramazan Alibekov, R. Mardanov, Enver Kеrimov, G. Puchkina, O. Bezrukov, A. Abdullaev
{"title":"RESULTS OF THE USE OF POLYVALENT BACTERIOPHAGES IN THE TREATMENT OF INFECTIOUS COMPLICATIONS IN EMERGENCY ABDOMINAL SURGERY","authors":"DMITRY PARSHIN, Vyacheslav Mykhaylichenko, A. Kupriyanov, Ramazan Alibekov, R. Mardanov, Enver Kеrimov, G. Puchkina, O. Bezrukov, A. Abdullaev","doi":"10.35630/2023/13/4.813","DOIUrl":null,"url":null,"abstract":"We comparatively studied the results of treatment of 86 patients with surgical infectious complications after cavitary intra-abdominal operations for emergency abdominal diseases. In the main group, treatment was supplemented with polyvalent bacteriophages. We studied integral scales for assessing the severity of patient’s condition of (APACHE II, ACI, ASEPSIS), microbial pattern, enteral morphofunctional coefficient, levels of alkaline phosphatase and intestinal alkaline phosphatase, and indicators of cellular immunity. The results of the study show that complex treatment including polyvalent bacteriophages in postoperative purulent-inflammatory complications in urgent surgery reduces the development of antibiotic-resistant strains, as well as the risk of nosocomial microbial wound associations. Enteral application of polyvalent bacteriophages in patients with acute intestinal failure syndrome normalizes microbial enteral imbalance and the level of pathogens contamination of the small intestine. Supplementing the treatment of postoperative abdominal purulent-inflammatory complications with phage therapy can reduce the number of surgical interventions, as well as the treatment duration and mortality.","PeriodicalId":51770,"journal":{"name":"Archiv EuroMedica","volume":" ","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2023-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archiv EuroMedica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35630/2023/13/4.813","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
We comparatively studied the results of treatment of 86 patients with surgical infectious complications after cavitary intra-abdominal operations for emergency abdominal diseases. In the main group, treatment was supplemented with polyvalent bacteriophages. We studied integral scales for assessing the severity of patient’s condition of (APACHE II, ACI, ASEPSIS), microbial pattern, enteral morphofunctional coefficient, levels of alkaline phosphatase and intestinal alkaline phosphatase, and indicators of cellular immunity. The results of the study show that complex treatment including polyvalent bacteriophages in postoperative purulent-inflammatory complications in urgent surgery reduces the development of antibiotic-resistant strains, as well as the risk of nosocomial microbial wound associations. Enteral application of polyvalent bacteriophages in patients with acute intestinal failure syndrome normalizes microbial enteral imbalance and the level of pathogens contamination of the small intestine. Supplementing the treatment of postoperative abdominal purulent-inflammatory complications with phage therapy can reduce the number of surgical interventions, as well as the treatment duration and mortality.
对比分析86例急腹症腹腔内腔手术后外科感染并发症的治疗效果。主组以多价噬菌体辅助治疗。我们研究了评估患者病情严重程度的积分量表(APACHE II, ACI, ASEPSIS),微生物模式,肠内形态功能系数,碱性磷酸酶和肠道碱性磷酸酶水平以及细胞免疫指标。该研究结果表明,包括多价噬菌体在内的综合治疗紧急手术术后脓性炎症并发症可减少抗生素耐药菌株的发展,以及院内微生物伤口关联的风险。急性肠衰竭综合征患者肠内应用多价噬菌体可使肠道微生物失衡和小肠病原体污染水平正常化。以噬菌体治疗辅助治疗术后腹部脓性炎症并发症,可减少手术干预次数,降低治疗时间和死亡率。